World · 1 sources covering this

Moderna stock jumps 120% after cancer vaccine trial win: What investors need to know

Moderna stock surged after its mRNA cancer vaccine showed positive Phase 3 results with Merck’s Keytruda, boosting hopes for a new melanoma treatment.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

Hindustan TimesLean L·2h ago
Moderna stock jumps 120% after cancer vaccine trial win: What investors need to know
Moderna stock surged after its mRNA cancer vaccine showed positive Phase 3 results with Merck’s Keytruda, boosting hopes for a new melanoma treatment.
Read at Hindustan Times →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/070e46deec383a31b245d1062b9e775f62a39518"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Moderna stock jumps 120% after cancer vaccine trial win: What investors need to know"></iframe>

Moderna stock jumps 120% after cancer vaccine trial win: What investors need to know

How 1 sources are covering this

Moderna stock jumps 120% after cancer vaccine trial win: What investors need to know

More from World

Bangladesh to hold presidential election on Thursday

Pakistan extends airspace ban for Indian aircraft till September 24

West Asia war LIVE: Iran's armed forces warn Gulf countries against assisting U.S. military

More than 100,000 ancient shipwrecks may be hiding beneath the Baltic Sea

Reader

Trust & legal

Across the network